Need professional-grade analysis? Visit stockanalysis.com
$4.65B
N/A
N/A
36.00%
Shandong Realcan Pharmaceutical Co Ltd (002589) trades on SHE in CNY. The company is classified in the Healthcare sector under the Medical Distribution industry. The stock currently trades at CNY3.35, down 2.33% from the previous close.
Over the past year, 002589 has traded between a low of CNY2.81 and a high of CNY4.69. The stock has gained 17.7% over this period. It is currently 28.6% below its 52-week high.
Shandong Realcan Pharmaceutical Co Ltd has a market capitalization of $4.65B and a dividend yield of 36.00%.
Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institutions in China. It operates through the Drug and Equipment Distribution, In Vitro Diagnostics, Pharmaceutical Logistics, Traditional Chinese Medicine, and Microbiome Medicine segments. The company engages in the processing, manufacture, sale, and wholesale of Chinese medicinal materials, herbal medicine, and patent medicine. It is also involved in the wholesale of biochemical, psychotropic, narcotic, and toxic drugs for medical use; chemical APIs, and preparations; antibiotics, biological products, anabolic steroids, peptide hormones, poppy shells, and pharmaceutical precursor chemicals; and medical devices. In addition, the company provides leasing of medical devices and technical services; investment management and consulting services; medical sterilization outsourcing and consulting services; health consulting services; and pharmaceutical logistics services. Further, it engages in the warehousing and distribution of drugs; technology development and transfer; and operation of a health service platform. The company was formerly known as Realcan Pharmaceutical Co., Ltd. and changed its name to Realcan Pharmaceutical Group Co., Ltd. in December 2018. Realcan Pharmaceutical Group Co., Ltd. was founded in 2004 and is based in Yantai, China.
Side-by-side comparison against top Healthcare peers.